Gelonghui November 15 | Bowling Bao (002286.SZ) said on the investor interactive platform that the company focuses on the R&D, production and sales of functional sugar products. At this stage, the company has expanded the application of erythritol and maltodextrin products with pharmaceutical excipient qualifications in the pharmaceutical field. Epomycin is an early cooperative project between the company and a third party, but has not yet been industrialized.
保龄宝(002286.SZ)：埃博霉素为公司早期与第三方合作项目，现在未实现产业化
Bowling Bao (002286.SZ): Epomycin was an early cooperative project between the company and a third party, and no industrialization has yet been achieved
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.